Sun Pharma Q2 Sales Rise 11.8% to Rs 161 Billion
Sun Pharmaceutical Industries reported consolidated sales of Rs 161 billion in the second quarter of FY27, up 11.8% year on year. Adjusted profit was Rs 31.62 billion.
Strong performance in India, emerging markets and the rest of the world supports quarterly growth, while India formulations sales increase 17.3 per centSun Pharmaceutical Industries reported an 11.8 per cent year-on-year increase in consolidated sales to Rs 161 billion in the second quarter of FY27…